Purpose: To determine if cytokine tear levels before hematopoietic stem cell transplantation
(HSCT) can help anticipate the occurrence of ocular chronic graft-versus-host disease …

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only curative treatment
for hematological malignancies. Chronic graft-versus-host disease (cGVHD) is a common …

Purpose: To develop a tear molecule level-based predictive model based on a panel of tear
cytokines and their correlation with clinical features in ocular chronic graft versus host …

Purpose To investigate the profile of cytokines in tear fluid of patients after allogeneic stem
cell transplantation (allo-SCT) and determine their relation to the presence and …

We investigated the tear cytokine profiles in patients who underwent stem cell
transplantation (SCT) and attempted to evaluate whether tear cytokines are associated with …

Aim To analyze tear cytokines levels and their correlation to ocular surface parameters in
allogenic hematopoietic stem cell transplants (allo-HSCT) patients. Methods Prospective …

This longitudinal cohort study compared ocular surface indicators in forty allogeneic
hematopoietic stem cell transplant (HSCT) subjects with twenty healthy controls at baseline …

Graft-versus-host disease (GVHD) is an immune-mediated inflammatory disease resulting
from destruction of host tissue by donor immunoreactive cells and occurs in 30% to 70% of …

Purpose To analyse the tear cytokine levels of patients diagnosed with ocular chronic graft-
versus-host disease (GVHD) and examine the consistency of these levels with different …

Purpose: To date, no biomarkers for ocular graft versus host disease (GvHD), a frequent
complication following allogeneic hematopoietic cell transplantation (HCT), exist. In this …